Cellular and molecular pathology of head and neck tumors
Head and Neck Cancer: Multimodality Management, Second Edition, Page: 77-99
2016
- 5Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Captures5
- Readers5
Book Chapter Description
Head and neck pathology encompasses a multitude of organs of diverse histogenesis. Malignancies arising from head and neck sites accordingly are diverse in origins, morphogenesis, and biological behavior. Excluding connective tissue and vascular entities, the main entities that are presented in this chapter include squamous mucosal site, salivary, thyroid and sinonasal, and skull base tumors. The histopathological classification remains the main reference to the diagnosis and, to a large extent, malignancy grading. Advances in immunohistochemical techniques and the development of reagents to cellular intermediate filaments and lineage markers have led to better diagnosis and categorization of undifferentiated entities with overlapping morphologic features. More recently, major strides have been achieved in the molecular genetic characterization and understanding of head and neck tumorigenesis. Although clinically applicable and validated, molecular biomarkers have yet to be realized; it is important to address the recent discoveries and their potential integration with the phenotypic and pathologic features. This chapter concisely presents the relevant pathomorphologic and molecular features of the tumors of the major head and neck sites for clinical management.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85017064202&origin=inward; http://dx.doi.org/10.1007/978-3-319-27601-4_3; http://link.springer.com/10.1007/978-3-319-27601-4_3; https://dx.doi.org/10.1007/978-3-319-27601-4_3; https://link.springer.com/chapter/10.1007/978-3-319-27601-4_3
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know